Researchers develop new method to identify vaccine targets

Researchers have identified a new means of developing vaccine targets that may allow them to cut off certain types of evolutionary defenses. Read More »

Naproxen shows antiviral activity against flu

Influenza Read More »

Rwandan health minister lauds successful launch of measles and rubella vaccine

Agn├Ęs Binagwaho Read More »

Measles guidelines on planes miss majority of infections

Measles Read More »

U.S. parents still cold on HPV vaccine

The number of U.S. parents concerned about possible side effects from the human papillomavirus virus vaccine has grown despite the insistence from doctors that it is safe and efficacious against cervical cancer. Read More »

UCLA creates method to predict possible pandemic origin locations

Researchers from the University of California Los Angeles have used a new method of analyzing flu surveillance and other data to predict that coastal and central China and Egypt's Nile Delta may become hotspots during the next pandemic influenza outbreak. Read More »

Key West official reacts to CDC dengue report

Dengue fever Read More »

U.K. publishes results of novel coronavirus investigation

Coronavirus Read More »

Greenphire announces payment system contract with Bavarian Nordic

Greenphire, a payment technology company for the clinical trials industry, recently announced that it has made a deal for Bavarian Nordic to use its ClinCard Technology Platform in a large, Phase III vaccine trial. Read More »

Advaxis nominated for Novartis award

Advaxis, Inc., a developer of next generation immunotherpies for cancer and infectious diseases, recently announced that his been nominated for an award by Novartis Vaccines and Diagnostics. Read More »